Skip to content
Home » Baxter International’s (BAX) CEO Robert Parkinson on Q3 2014 Results – Earnings Call Transcript

Baxter International’s (BAX) CEO Robert Parkinson on Q3 2014 Results – Earnings Call Transcript

Baxter International Inc. (NYSE:BAX)

Q3 2014 Results Earnings Conference Call

October 16, 2014, 08:30 AM ET


Robert L. Parkinson, Jr. – Chairman and CEO

Ludwig N. Hantson – President, BioScience

Robert J. Hombach – Corporate VP and CFO

Mary Kay Ladone – Corporate VP, IR


David Roman – Goldman Sachs

David Lewis – Morgan Stanley

Matt Miksic – Piper Jaffray

Robert Hopkins – BAML

Mike Weinstein – JPMorgan

Lawrence S. Keusch – Raymond James & Associates, Inc.

Kristen Stewart – Deutsche Bank

Bruce Nudell – Credit Suisse

Glenn Novarro – RBC Capital Markets


Good morning ladies and gentlemen and welcome to the Baxter International’s, third quarter earnings conference call. Your lines will remain in a listen-only mode until the question-and-answer segment of today’s call (Operator Instructions). As a reminder this call is being recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter’s permission. If you have any objections, please disconnect at this time.

I would now like to turn the call over to Ms. Mary Kay Ladone, Corporate Vice President, Investor Relations at Baxter International. Ms. Ladone, you may begin.

Mary Kay Ladone – Corporate VP, IR

Thanks Pam. Good morning everyone and welcome to our Q3, 2014 earnings conference call. Joining me today are Bob Parkinson, CEO and Chairman of Baxter International; Ludwig Hantson, President, BioScience; and Bob Hombach, Chief Financial Officer.

Before we get started, let me remind you that this presentation, including comments regarding our financial outlook, new product developments and regulatory matters contain forward-looking statements that involve risks and uncertainties and of course our actual results could differ materially from our current expectations. Please refer to today’s press release and our SEC filings for more detailed concerning factors that could cause actual results to differ materially.

In addition, in today’s call, non-GAAP financial measures will be used to help investors understand Baxter’s ongoing business performance. A reconciliation of the non-GAAP financial measures being discussed today to the comparable GAAP financial measures is included in our earnings release issued this morning and available on our website.

Pages: First |1 | ... | Next → | Last | View Full Transcript